Ardelyx, Inc. (ARDX): Price and Financial Metrics

Ardelyx, Inc. (ARDX)

Today's Latest Price: $7.00 USD

0.15 (-2.10%)

Updated Dec 13 6:55pm

Add ARDX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 325 in Biotech

See all "A" rated Strong Buy stocks

ARDX Stock Summary

  • Ardelyx Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 7.4% of US listed stocks.
  • ARDX's price/sales ratio is 1,219.48; that's higher than the P/S ratio of 99.7% of US stocks.
  • As for revenue growth, note that ARDX's revenue has grown -99.38% over the past 12 months; that beats the revenue growth of merely 0.49% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Ardelyx Inc are PSTI, AUPH, RARX, RVNC, and NK.
  • ARDX's SEC filings can be seen here. And to visit Ardelyx Inc's official web site, go to
ARDX Daily Price Range
ARDX 52-Week Price Range

ARDX Stock Price Chart More Charts

ARDX Price/Volume Stats

Current price $7.00 52-week high $8.31
Prev. close $7.15 52-week low $1.60
Day low $6.84 Volume 689,500
Day high $7.16 Avg. volume 543,217
50-day MA $5.79 Dividend yield N/A
200-day MA $3.89 Market Cap 460.61M

Ardelyx, Inc. (ARDX) Company Bio

Ardelyx is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, minimally-systemic, small molecule therapeutics that work exclusively in the gastrointestinal tract to treat cardio-renal, gastrointestinal and metabolic diseases. The company was founded in 2007 and is based in Fremont, California.

ARDX Latest News Stream

Event/Time News Detail
Loading, please wait...

ARDX Latest Social Stream

Loading social stream, please wait...

View Full ARDX Social Stream

ARDX Price Returns

1-mo 14.01%
3-mo 49.57%
6-mo 174.51%
1-year 225.58%
3-year -51.56%
5-year -70.12%
YTD 291.06%
2018 -72.88%
2017 -53.52%
2016 -21.63%
2015 -4.08%
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5047 seconds.